SHPH Shuttle Pharmaceuticals Holdings, Inc. - common stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Sep 24, 2026
$4.17
· of 52w range
· above low
· to high
$0.4952w low
$6.1552w high
Market Cap (MRQ)
$4M
P/E
-0.1
EPS
$-7.16
your badges
52W Range
$0–$6
Analyst Rating
·
Price Target
·
P/E
-0.1
ROE
-400.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
SHPH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.17
Market Cap (MRQ)
$4M
P/E
-0.1
EPS
$-7.16
ROE
-400.1%
52W Range
$0–$6
SHPH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 11, 2026 | 1-for-10 | Reverse |
| June 16, 2025 | 1-for-25 | Reverse |
| Aug. 13, 2024 | 1-for-8 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-7.162022-12-31 → 2025-12-31
Free Cash Flow·2023-12-31 → 2023-12-31
Net margin·2023-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | SHPH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.15Y avg ≈-26.0 | ≈-26.0 | · | · | |
| P/B (MRQ) | 0.25Y avg ≈273.2 | ≈273.2 | 1.0 | Undervalued | |
| Price / Cash Flow | -0.15Y avg ≈-659.9 | ≈-659.9 | · | · | |
| Price / Tangible Book (MRQ) | 0.45Y avg ≈392.8 | ≈392.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | SHPH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -180.6%5Y avg ≈-154.0% | ≈-154.0% | -59.2% | Weak | |
| ROE | -400.1%5Y avg ≈859.7% | ≈859.7% | -89.1% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | SHPH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.15Y avg ≈3.4 | ≈3.4 | 2.3 | Low liquidity | |
| Quick Ratio | 0.05Y avg ≈3.3 | ≈3.3 | 3.1 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | SHPH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 0.00% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $4M | $4M | $4M | $1M | $1M | |
| SG&A Expense | $6M | $1M | $1M | $473.7K | $36.5K | |
| Operating Expenses | $12M | $8M | $6M | $2M | $2M | |
| Operating Income | $-12M | $-8M | $-6M | $-2M | $-2M | |
| Interest Income | $1.1K | $38.1K | $79.1K | · | · | |
| Other Non-op | $195.2K | $-1M | $-700.3K | $-3M | $590.9K | |
| Pretax Income | · | · | $-7M | $-5M | $-1M | |
| Net Income | $-12M | $-9M | $-7M | $-5M | $-1M | |
| EPS (Basic) | $-7.16 | $-79.65 | $-3.53 | $-5.04 | $-0.12 | |
| EPS (Diluted) | $-7.16 | $-82.60 | $-3.53 | $-5.04 | · | |
| Shares (Basic) | 1,637,926 | 114,807 | 1,866,275 | 1,337,742 | 9,301,750 | |
| Shares (Diluted) | 1,637,926 | 115,493 | 1,866,275 | 1,337,742 | · | |
| EBITDA | $-12M | $-8M | $-6M | $-3M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $334.0K | $2M | $3M | $8M | $504.7K | |
| Short-term Investments | · | · | $3M | · | · | |
| Prepaid Expense | $168.9K | $290.8K | $114.5K | $161.1K | $4.9K | |
| Current Assets | $502.9K | $2M | $6M | $9M | $509.6K | |
| PP&E (Net) | $17.3K | $19.4K | $24.8K | $12.6K | $18.6K | |
| PP&E (Gross) | · | · | · | $127.5K | $127.5K | |
| Accum. Depreciation | · | · | $121.7K | $114.9K | $108.9K | |
| Intangibles | $10M | · | · | · | · | |
| Other Non-current Assets | · | · | · | $6.5K | · | |
| Total Assets | $10M | $3M | $6M | $9M | $651.6K | |
| Accounts Payable | $1M | $596.6K | · | · | · | |
| Short-term Debt | · | $190.3K | · | $685.5K | · | |
| Current Liabilities | $8M | $2M | $1M | $975.7K | $2M | |
| Capital Leases | $155.0K | $238.1K | $304.1K | · | $62.4K | |
| Total Liabilities | $8M | $2M | $2M | $975.7K | $2M | |
| Long-term Debt | · | · | · | · | $91.0K | |
| Common Stock | $2 | $2 | $20 | $17 | $93 | |
| Paid-in Capital | $49M | $35M | $29M | $27M | $12M | |
| Retained Earnings | $-46M | $-35M | $-25M | $-19M | $-14M | |
| Stockholders' Equity | $2M | $709.2K | $4M | $8M | $-2M | |
| Liabilities + Equity | $10M | $3M | $6M | $9M | $651.6K | |
| Shares Outstanding | 202,362 | 163,093 | 2,008,689 | 1,700,414 | 9,312,152 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $290.1K | $5.5K | · | · | · | |
| Stock-based Comp | $933.0K | $259.7K | $182.0K | $237.5K | $910.1K | |
| Amort. of Intangibles | $288.1K | · | · | · | · | |
| Operating Cash Flow | $-9M | $-7M | $-6M | $-3M | $-300.3K | |
| CapEx | · | · | $19.0K | · | · | |
| Investing Cash Flow | $-3M | $3M | $-3M | · | · | |
| Net Debt Issued | · | $-59.7K | · | · | · | |
| Stock Issued | · | $4M | · | $10M | · | |
| Net Stock Activity | · | $4M | · | $10M | · | |
| Financing Cash Flow | $11M | $4M | $3M | $11M | $687.9K | |
| Net Change in Cash | $-2M | $-656.3K | $-6M | $8M | $387.6K | |
| Free Cash Flow | · | · | $-6M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | · | -7696.2% | -11148.2% | · | · | |
| Net Margin | · | -9144.8% | -12473.2% | · | · | |
| Pretax Margin | · | · | -12473.2% | · | · | |
| EBITDA Margin | · | -7696.2% | -11148.2% | · | · | |
| ROA | -180.6% | -216.2% | · | -65.1% | · | |
| ROE | -400.1% | 3017.0% | · | -37.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 1.4 | · | 8.8 | · | |
| Quick Ratio | 0.0 | 1.3 | · | 8.6 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $1.11 | $0.17 | · | $0.56 | · | |
| Revenue / Share | · | $0.03 | $0.03 | · | · | |
| Cash Flow / Share | $-5.79 | $-2.54 | $-2.99 | · | · | |
| Cash / Share | $0.17 | $0.47 | · | $0.62 | · | |
| EPS (TTM) | $-7.16 | $-82.60 | $-3.53 | $-5.04 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | 0.00% | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-12M | $-9M | $-7M | $-5M | · | |
| Market Cap | $4M | $88M | · | $5.33B | · | |
| P/E | -0.3 | -0.3 | -25.8 | -77.8 | · | |
| P/B | 1.6 | 123.4 | · | 694.5 | · | |
| P / Tangible Book | · | 123.4 | 360.6 | 694.5 | · | |
| P / Cash Flow | -0.4 | -11.9 | · | -1967.4 | · | |
| Earnings Yield | -397.8% | -384.6% | -3.9% | -1.3% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $55.7K | $267.2K | $511.9K | $943.5K | $1M | $2M | $986.4K | $1M | $645.7K | $586.1K | $710.5K | $1M | $839.7K | $921.8K | $-1.4K | $669.0K | |
| SG&A Expense | $2M | $1M | $2M | $886.1K | $2M | $596.9K | $429.1K | $329.0K | $310.0K | $324.6K | $316.7K | $265.6K | $209.3K | $255.4K | $369.0K | $81.9K | |
| Operating Expenses | $4M | $2M | $3M | $2M | $4M | $3M | $2M | $3M | $1M | $1M | $1M | $2M | $1M | $2M | $530.3K | $821.5K | |
| Operating Income | $-4M | $-2M | $-3M | $-2M | $-4M | $-3M | $-2M | $-3M | $-1M | $-1M | $-1M | $-2M | $-1M | $-2M | $-530.3K | $-821.5K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $623.5K | · | · | · | · | |
| Interest Income | $90 | $209 | $523 | $486 | $81 | · | $3 | $2.5K | $14.2K | $21.5K | $22.4K | $20.8K | $19.3K | $16.7K | · | · | |
| Other Non-op | $804.0K | $64.4K | $173.3K | $-80.4K | $203.9K | $-101.8K | $178.7K | $-732.5K | $-548.6K | $-346.2K | $-357.7K | $-193.6K | $-718.7K | $569.7K | $-2M | $-177.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | $-975.1K | $-3M | $-998.4K | |
| Net Income | $-3M | $-2M | $-3M | $-2M | $-4M | $-3M | $-2M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-975.1K | $-3M | $-998.4K | |
| EPS (Basic) | $-3.10 | $-0.43 | $-2.52 | $-1.05 | $-32.91 | $-7.60 | $-14.87 | $-39.83 | $-24.12 | $-0.83 | $-0.82 | $-0.91 | $-1.23 | $-0.57 | $-4.81 | $-0.10 | |
| EPS (Diluted) | $-3.10 | $-0.43 | $-2.52 | $-1.05 | $-32.91 | $-7.60 | $-17.82 | $-39.83 | $-24.12 | $-0.83 | $-0.82 | $-0.91 | $-1.23 | $-0.57 | $-4.81 | $-0.10 | |
| Shares (Basic) | 1,015,181 | 5,031,569 | · | 2,233,650 | 112,611 | 401,957 | · | 95,004 | 84,197 | 2,075,745 | · | 1,969,904 | 1,780,171 | 1,704,517 | · | 10,164,979 | |
| Shares (Diluted) | 1,015,181 | 5,031,569 | · | 2,233,650 | 112,611 | 401,957 | · | 95,004 | 84,197 | 2,075,745 | · | 1,969,904 | 1,780,171 | 1,704,517 | · | · | |
| EBITDA | $-4M | $-2M | · | $-2M | $-4M | $-3M | · | $-3M | $-1M | $-1M | · | $-2M | $-1M | $-2M | · | $-821.5K |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $90.2K | $1M | $334.0K | $2M | $5M | $5M | $2M | $156.7K | $695.6K | $1M | $3M | $4M | $5M | $7M | $8M | $9M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $2M | $3M | $3M | $3M | $3M | $3M | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.0K | |
| Prepaid Expense | $306.1K | $1M | $168.9K | $1M | $374.2K | $446.8K | $290.8K | $103.0K | $139.5K | $129.6K | $114.5K | $170.1K | $78.9K | $203.8K | $161.1K | $163.1K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $81.5K | · | $6.5K | $6.5K | · | · | · | |
| Current Assets | $396.4K | $2M | $502.9K | $3M | $5M | $5M | $2M | $361.4K | $2M | $4M | $6M | $7M | $8M | $10M | $9M | $9M | |
| PP&E (Net) | $15.2K | $16.3K | $17.3K | $18.3K | $19.3K | $18.4K | $19.4K | $21.2K | $22.0K | $22.9K | $24.8K | $26.8K | $9.6K | $11.1K | $12.6K | $14.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $127.5K | · | $127.5K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $116.4K | $114.9K | $113.4K | |
| Intangibles | $9M | $9M | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.5K | · | |
| Total Assets | $23M | $12M | $10M | $4M | $6M | $5M | $3M | $673.6K | $3M | $5M | $6M | $7M | $9M | $10M | $9M | $9M | |
| Accounts Payable | $3M | $2M | $1M | $1M | $1M | $896.9K | $596.6K | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | · | · | · | · | $190.3K | · | · | · | · | · | · | $139.2K | · | · | |
| Current Liabilities | $3M | $8M | $8M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $810.4K | $493.7K | $1M | $975.7K | $970.5K | |
| Capital Leases | $112.3K | $134.1K | $155.0K | $175.3K | $195.2K | $220.1K | $238.1K | $255.6K | $267.0K | $288.6K | $304.1K | $308.4K | $329.8K | $751.7K | · | $6.7K | |
| Total Liabilities | $4M | $8M | $8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $975.7K | $977.1K | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $139.2K | · | · | |
| Common Stock | $9 | $57 | $20 | $13 | $11 | $63 | $2 | $29 | $21 | $21 | $20 | $160 | $155 | $137 | $17 | $136 | |
| Paid-in Capital | $71M | $52M | $49M | $45M | $45M | $41M | $35M | $32M | $30M | $30M | $29M | $19M | $19M | $17M | $27M | · | |
| Retained Earnings | $-52M | $-48M | $-46M | $-44M | $-41M | $-38M | $-35M | $-33M | $-29M | $-27M | $-25M | $-14M | $-12M | $-10M | $-19M | $-8M | |
| Stockholders' Equity | $19M | $3M | $2M | $1M | $4M | $3M | $709.2K | $-1M | $801.4K | $3M | $4M | $6M | $7M | $7M | $8M | $8M | |
| Liabilities + Equity | $23M | $12M | $10M | $4M | $6M | $5M | $3M | $673.6K | $3M | $5M | $6M | $7M | $9M | $10M | $9M | $9M | |
| Shares Outstanding | 1,001,165 | 5,551,290 | 2,023,615 | 1,235,507 | 1,070,773 | 6,382,694 | 163,093 | 2,946,099 | 2,106,233 | 2,102,511 | 2,008,689 | 15,999,125 | 15,482,038 | 13,654,127 | 1,700,414 | 13,586,393 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $633.5K | $633.3K | · | · | $-979 | $1.0K | · | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $-7.5K | $35.0K | $214.8K | $134.3K | $46.9K | $537.0K | $31.9K | $45.3K | $71.2K | $111.4K | $86.5K | $37.6K | $49.5K | $8.3K | $-119.2K | $23.7K | |
| Amort. of Intangibles | $632.3K | $632.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-567.6K | $-2M | $-973.0K | $-3M | $-3M | $-3M | $-3M | $-2M | $-1M | $-1M | $-1M | $-2M | $-2M | $-1M | $-635.8K | $-1M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | $-5M | $-36.0K | · | · | · | · | $0 | $2M | $1M | $101.3K | $87.0K | $-25.9K | $62.8K | $-3M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | |
| Stock Issued | $0 | $3M | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $3M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $3M | $2M | $-96.4K | $4M | $5M | $4M | $-196.8K | $-461.7K | $-40.0K | $-334.4K | $0 | $-139.2K | $3M | $-67.4K | $10M | |
| Net Change in Cash | $-999.7K | $755.9K | $-2M | $-3M | $305.1K | $3M | $2M | $-538.9K | $-703.0K | $-1M | $-1M | $-2M | $-2M | $-1M | $-703.2K | $9M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -10144.7% | · | · | · | -11985.3% | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -7565.3% | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -7565.3% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -10144.7% | · | · | · | -11985.3% | · | · | |
| ROA | -22.2% | -25.1% | · | -111.3% | -89.1% | -60.7% | · | -94.0% | -34.9% | · | · | -21.4% | -49.4% | -18.7% | · | -21.3% | |
| ROE | -27.6% | -64.9% | · | -5958.8% | -168.2% | -101.0% | · | -176.2% | -52.5% | · | · | -25.6% | -63.0% | -28.2% | · | -23.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.3 | · | 1.7 | 3.1 | 2.8 | · | 0.2 | 1.8 | 3.0 | · | 8.6 | 17.1 | 7.5 | · | 9.6 | |
| Quick Ratio | 0.0 | 0.1 | · | 1.1 | 2.8 | 2.5 | · | 0.1 | 1.7 | 2.8 | · | 8.4 | 16.9 | 7.3 | · | 9.4 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.0 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.16 | · | · | $1.13 | $3.37 | $0.51 | · | $-0.45 | $0.38 | $1.31 | · | $0.35 | $0.45 | $0.51 | · | $0.62 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | $0.01 | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | · | · | · | $-0.25 | · | · | · | $-0.60 | · | · | · | · | · | · | |
| Cash / Share | $0.09 | · | · | $1.70 | $4.50 | $0.71 | · | $0.05 | $0.33 | $0.67 | · | $0.24 | $0.35 | $0.53 | · | $0.67 | |
| EPS (TTM) | $-7.10 | $-7.29 | · | $-29.76 | $-68.54 | $-89.37 | · | $-65.60 | $-26.68 | $-3.79 | · | $-7.52 | $-6.71 | $-5.54 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-10M | $-11M | · | $-11M | $-12M | $-10M | · | $-9M | $-7M | $-7M | · | $-8M | $-7M | $-5M | · | $-3M | |
| Market Cap | $3M | · | · | $4M | $4M | $62M | · | $98M | $168M | $171M | · | $1.95B | $3.56B | $3.63B | · | $12.47B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.62B | · | · | |
| P/E | -0.5 | -0.1 | · | -0.1 | -0.1 | -0.1 | · | -0.5 | -3.0 | -21.4 | · | -16.2 | -34.3 | -48.0 | · | · | |
| P/B | 0.2 | · | · | 3.1 | 1.1 | 18.9 | · | -74.5 | 210.2 | 61.8 | · | 347.9 | 513.4 | 525.9 | · | 1483.9 | |
| P / Tangible Book | 0.3 | · | · | 3.1 | 1.1 | 18.9 | · | · | 210.2 | 61.8 | · | 347.9 | 513.4 | 525.9 | · | 1483.9 | |
| P / Cash Flow | · | · | · | · | · | -24.6 | · | · | · | -137.8 | · | · | · | -2714.5 | · | · | |
| Earnings Yield | -218.5% | -1073.6% | · | -838.3% | -1820.5% | -919.0% | · | -197.3% | -33.4% | -4.7% | · | -6.2% | -2.9% | -2.1% | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Margin % | · | -7696.2% | -11148.2% | · | · |
| Net Income | $-12M | $-9M | $-7M | $-5M | $-1M |
| Diluted EPS | $-7.16 | $-82.60 | $-3.53 | $-5.04 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 0.1 | 1.4 | · | 8.8 | · |
| Quick Ratio | 0.0 | 1.3 | · | 8.6 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | $-6M | · | · |
Institutional owners (13F)
Institutional activity — Q1 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (-2 vs prior Q) | 3 (+2 vs prior Q) | 2 (0 vs prior Q) | 1 (0 vs prior Q) | +42K |
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Company insiders 15 insiders · 6 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Anatoly Dritschilo | CEO and Chairman | Aug. 14, 2023 G | 2,100,000 | 0 | 0 | $0 |
| Timothy J. Lorber | Chief Financial Officer | Aug. 8, 2025 A | · | 0 | 0 | $0 |
| Hoek Michael Vander | Chief Financial Officer | March 8, 2024 A | 103,852 | 0 | 0 | $0 |
| Peter Dritschilo | President and COO | Dec. 29, 2022 S | 6,560 | 0 | 0 | $0 |
| Mira Jung | Chief Scientific Officer | May 1, 2024 A | 135,715 | 0 | 0 | $0 |
| Tyvin Rich | Chief Medical Officer | Dec. 29, 2022 S | 2,429 | 0 | 0 | $0 |
| Joseph Tung | Director | Aug. 8, 2025 A | · | 0 | 0 | $0 |
| Oleh Nabyt | Director | Aug. 8, 2025 A | · | 0 | 0 | $0 |
| George Scorsis | Director | Aug. 8, 2025 A | · | 0 | 0 | $0 |
| Steven M Richards | Director | Aug. 8, 2025 A | 1,707 | 0 | 0 | $0 |
| Bette Jacobs | Director | Dec. 13, 2023 S | 27,064 | 0 | 0 | $0 |
| Milton Brown | Director | Dec. 13, 2023 S | 1,094,610 | 0 | 0 | $0 |
| Chris Senanayake | Director | Dec. 29, 2022 S | 2,791 | 0 | 0 | $0 |
| HRT FINANCIAL LP | 10% owner | July 14, 2026 S | 0 | 6 | 5 | $-323,066 |
| William Adkins | · | Sept. 2, 2022 J | 184,071 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Sep 24, 2026